A major subset of patients with ankylosing spondylitis followed up in tertiary clinical care require anti-tumour necrosis factor alpha biological treatments according to the current guidelines.
作者信息
Temel M, Atagündüz P, Direskeneli H
出版信息
Ann Rheum Dis. 2005 Sep;64(9):1383-4. doi: 10.1136/ard.2004.028423.
Abstract
摘要
相似文献
1
A major subset of patients with ankylosing spondylitis followed up in tertiary clinical care require anti-tumour necrosis factor alpha biological treatments according to the current guidelines.
Ann Rheum Dis. 2005 Sep;64(9):1383-4. doi: 10.1136/ard.2004.028423.
2
Established criteria for disease controlling drugs in ankylosing spondylitis.
Ann Rheum Dis. 2003 Sep;62(9):793-4. doi: 10.1136/ard.62.9.793.
3
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis.
Ann Rheum Dis. 2006 Dec;65(12):1620-5. doi: 10.1136/ard.2005.042630. Epub 2006 Feb 7.
4
Anti-tumour necrosis factor therapy in ankylosing spondylitis. A need for guidelines.
Rheumatology (Oxford). 2003 Mar;42(3):490. doi: 10.1093/rheumatology/keg113.
5
The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
Rheumatology (Oxford). 2005 Oct;44(10):1277-81. doi: 10.1093/rheumatology/keh713. Epub 2005 Aug 16.
6
BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.
Rheumatology (Oxford). 2005 Jul;44(7):939-47. doi: 10.1093/rheumatology/keh669. Epub 2005 May 18.
7
Assessment of patients with spondyloarthropathies for treatment with tumour necrosis factor alpha blockade.
Rheumatology (Oxford). 2005 Jan;44(1):17-23. doi: 10.1093/rheumatology/keh358. Epub 2004 Aug 24.
8
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.
Ann Rheum Dis. 2006 Mar;65(3):316-20. doi: 10.1136/ard.2005.040758. Epub 2005 Aug 11.
9
Developments and current pharmacotherapeutic recommendations for ankylosing spondylitis.
Expert Opin Pharmacother. 2006 May;7(7):869-83. doi: 10.1517/14656566.7.7.869.
10
The impact of the NICE appraisal consultation document on anti-TNF therapy for ankylosing spondylitis.
Rheumatology (Oxford). 2007 Jun;46(6):1044-5. doi: 10.1093/rheumatology/kem065. Epub 2007 Mar 31.
Zotero 插件